Myriad Genetics, Inc. (MYGN) shares outstanding

Shares outstanding · fiscal 2025
92.60M

Myriad Genetics, Inc. (MYGN) had 92.60M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.2% higher than the 90.60M of fiscal 2024. Figures as of 18 Nov 2026, 12:36 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
92.60M
Change on fiscal 2024
+2.2%
Growth, 5 years
+4.5% a year
Growth, 10 years
+2.2% a year
Highest on record
99.15Mfiscal 2010
Lowest on record
68.80Mfiscal 2017
Fiscal years on record
182009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Myriad Genetics, Inc. shares outstanding, in more detail

The market data feed counts 95.92M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 4.5% a year; over ten years the rate was 2.2% a year. Across the 18 fiscal years on record (2009–2025), the highest was 99.15M in fiscal 2010 and the lowest 68.80M in fiscal 2017.

History · 18 fiscal years

Shares outstanding by fiscal year

Myriad Genetics, Inc. shares outstanding, year by year

Myriad Genetics, Inc. (MYGN) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202592.60M 2.2% up
202490.60M 9.4% up
202382.80M 2.7% up
202280.60M 3.3% up
202178.00M 4.3% up
202074.80M—
202074.30M 2.2% down
201976.00M 5.6% up
201872.00M 4.7% up
201768.80M 6.3% down
201673.40M 1.5% down
201574.50M 4.7% down
201478.20M 6.1% down
201383.30M 3.7% down
201286.47M 5.7% down
201191.70M 7.5% down
201099.15M 0.6% up
200998.57M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on MYGN

Myriad Genetics, Inc., figure by figure

Myriad Genetics, Inc. (MYGN) overview: price, valuation and scorecard

Myriad Genetics, Inc. shares outstanding: questions and answers

How many shares does Myriad Genetics, Inc. have?

Myriad Genetics, Inc. (MYGN) had 92.60M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.2% higher than the 90.60M of fiscal 2024. The market data feed counts 95.92M shares outstanding today.

What is the growth rate of Myriad Genetics, Inc.'s diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 4.5% a year; over ten years the rate was 2.2% a year.

What are the highest and lowest diluted share count figures on record for Myriad Genetics, Inc.?

Across the 18 fiscal years on record (2009–2025), the highest was 99.15M in fiscal 2010 and the lowest 68.80M in fiscal 2017.

How is Myriad Genetics, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Myriad Genetics, Inc. it is on record here for 18 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Myriad Genetics, Inc. (MYGN) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/MYGN/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.